Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -71.57% is 26% above its 5-year average of -96.20%, near the high end of its 5-year range (-158.56%–-48.03%).
As of the fiscal period ended Tuesday, June 30, 2026. 18.66% above its 12-month average of -87.99%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -71.57%.
RETURN ON EQUITY (ROE)
-71.57%
RETURN ON EQUITY (ROE) AVG TTM
-87.99%
RETURN ON EQUITY (ROE) AVG 3Y
-76.30%
RETURN ON EQUITY (ROE) AVG 5Y
-96.20%
RETURN ON EQUITY (ROE) AVG 10Y
-107.98%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+18.66%
CURRENT VS 3Y AVG
+6.19%
CURRENT VS 5Y AVG
+25.60%
CURRENT VS 10Y AVG
+33.72%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.76%
median of 689 covered companies
CURRENT VS SECTOR MEDIAN
-75.60%
vs the sector median at left
Marker Therapeutics, Inc.
Market Cap
$17.01M
Return on Equity (ROE)
-71.57%
TTM Avg
-87.99%
3Y Avg
-76.30%
5Y Avg
-96.20%
Market Cap
$17.14M
Return on Equity (ROE)
-125.30%
TTM Avg
118.50%
3Y Avg
7030.24%
5Y Avg
4638.47%
Market Cap
$17.15M
Return on Equity (ROE)
-54.45%
TTM Avg
-33.23%
3Y Avg
-44.23%
5Y Avg
-52.50%
Market Cap
$17.23M
Return on Equity (ROE)
-34.50%
TTM Avg
-796.82%
3Y Avg
-138.82%
5Y Avg
-407.45%
Market Cap
$16.64M
Return on Equity (ROE)
-101.76%
TTM Avg
-188.04%
3Y Avg
-167.76%
5Y Avg
-134.95%
Market Cap
$16.50M
Return on Equity (ROE)
N/A
TTM Avg
-416.37%
3Y Avg
-259.03%
5Y Avg
-190.00%
Market Cap
$17.60M
Return on Equity (ROE)
N/A
TTM Avg
-3014.83%
3Y Avg
-1589.49%
5Y Avg
-1032.64%
Market Cap
$17.72M
Return on Equity (ROE)
-117.98%
TTM Avg
-84.94%
3Y Avg
-64.05%
5Y Avg
-76.29%
Market Cap
$16.08M
Return on Equity (ROE)
N/A
TTM Avg
54.00%
3Y Avg
301.36%
5Y Avg
162.15%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | $17.01M | -71.57% | -87.99% | -76.30% | -96.20% |
| Palatin Technologies, Inc. (PTN)vs › | $17.14M | -125.30% | 118.50% | 7030.24% | 4638.47% |
| Lipocine Inc. (LPCN)vs › | $17.15M | -54.45% | -33.23% | -44.23% | -52.50% |
| PAVmed Inc. (PAVM)vs › | $17.23M | -34.50% | -796.82% | -138.82% | -407.45% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | -101.76% | -188.04% | -167.76% | -134.95% |
| Dyadic International, Inc. (DYAI)vs › | $16.50M | N/A | -416.37% | -259.03% | -190.00% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.60M | N/A | -3014.83% | -1589.49% | -1032.64% |
| Cosmos Health Inc. (COSM)vs › | $17.72M | -117.98% | -84.94% | -64.05% | -76.29% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $16.08M | N/A | 54.00% | 301.36% | 162.15% |
| BioCardia, Inc. (BCDA)vs › | $15.78M | -271.81% | -934.34% | -347.56% | -265.02% |
ROE
-71.6%
ROA
-59.7%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -71.57% |
| 2026-03-31 | -78.98% |
| 2025-12-31 | -72.42% |
| 2025-09-30 | -77.75% |
| 2025-06-30 | -139.25% |
| 2025-03-31 | -88.22% |
| 2024-12-31 | -57.82% |
| 2024-09-30 | -130.16% |
| 2024-06-30 | -106.88% |
| 2024-03-31 | -48.03% |
| 2023-12-31 | -58.61% |
| 2023-09-30 | -55.61% |
| 2023-06-30 | -69.49% |
| 2023-03-31 | -157.02% |
| 2022-12-31 | -152.70% |
| 2022-09-30 | -158.56% |
| 2022-06-30 | -147.53% |
| 2022-03-31 | -120.46% |
| 2021-12-31 | -95.21% |
| 2021-09-30 | -77.70% |
| 2021-06-30 | -56.24% |
| 2021-03-31 | -42.76% |
| 2020-12-31 | -104.98% |
| 2020-09-30 | -82.61% |
| 2020-06-30 | -67.70% |
| 2020-03-31 | -57.21% |
| 2019-12-31 | -48.60% |
| 2019-09-30 | -317.26% |
| 2019-06-30 | -293.44% |
| 2019-03-31 | -269.88% |
| 2018-12-31 | -249.33% |
| 2018-06-30 | -354.15% |
| 2017-12-31 | -300.21% |
| 2017-09-30 | -166.37% |
| 2017-06-30 | -93.31% |
| 2017-03-31 | -3.04% |
| 2016-12-31 | -39.71% |
| 2016-09-30 | -240.22% |
